Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib

HEMATOLOGICAL ONCOLOGY(2022)

引用 0|浏览4
暂无评分
摘要
The peer review history for this article is available at https://publons.com/publon/10.1002/hon.3039. The data that support the findings of this study are available from the corresponding author upon reasonable request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
更多
查看译文
关键词
chronic lymphocytic leukemia,residual disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要